Investor profile
Norcliffe Capital has backed 3 European tech companies across 3 funding rounds between 2023 and 2025, joining rounds totalling €23M. Most active in Healthtech. Data as of 7 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Dxcover | UK | 1 | €11M |
| Laverock Therapeutics | UK | 1 | €7.6M |
| Glen Clova Scientific | UK | 1 | €4.7M |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Dxcover | Series A | €11M | 2023-02 |
| Laverock Therapeutics | Seed | €7.6M | 2025-06 |
| Glen Clova Scientific | Seed | €4.7M | 2024-04 |
